Now Available

Oxbryta is indicated for the treatment of sickle cell disease (SCD)
in adults and pediatric patients 12 years of age and older.1

Get your patients started with Oxbryta support

Patient enrollment in the GBT Source Solutions program will help provide a path to receiving Oxbryta and access to a broad range of patient support offerings.

For any questions about enrollment or patient resources, please call a member of our Care Team at 833-GBT-4YOU (833-428-4968), Monday–Friday, 8:00 AM–8:00 PM ET.

Enroll your patients

Complete a GBT Source Patient Enrollment Form online using the GBT Source portal.

Enroll at GBT Source Download Enrollment Form

Stay up to date

Get information about Oxbryta and sickle cell disease delivered directly to your inbox.